| kidney disease | Q1054718 |
| Q112955580 | "Created equal" - A kaupapa Māori analysis of research and health system perspectives of inequity in chronic kidney disease in Aotearoa |
| Q67408967 | "Magnification phenomenon" in chronic renal disease |
| Q70315550 | 3,5-Diiodotyrosine and thyronine in the urine of patients with chronic renal disease |
| Q42584375 | 8th International Symposium on Growth and Nutrition in Children with Chronic Renal Disease: 28-30 May 2009, Oviedo, Asturias, Spain |
| Q37311560 | A 44 year-old lady with chronic renal disease and intractable ulcers: a case report |
| Q48573170 | A Clinical Lecture ON TWO CASES OF CHRONIC RENAL DISEASE: A Contrast in Treatment and Prognosis |
| Q89773525 | A Clinical Review on Nutritional Requirements and Assessment for Type 2 Diabetes Mellitus with Chronic Renal Disease |
| Q34947392 | A granulocyte inhibitory protein overexpressed in chronic renal disease regulates expression of interleukin 6 and interleukin 8. |
| Q52669399 | A new perspective on the pathogenesis of chronic renal disease in captive cheetahs (Acinonyx jubatus). |
| Q92277895 | A new predictor for new-onset atrial fibrillation in patients with ST elevation myocardial infarction: chronic renal disease |
| Q35023531 | A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study. |
| Q70379740 | A possible mechanism for increased susceptibility to aminoglycoside nephrotoxicity in chronic renal disease |
| Q38300394 | A possible mechanism for the progression of chronic renal disease and congestive heart failure |
| Q42983959 | A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis. |
| Q36979549 | A rare bacteremia caused by Cedecea davisae in patient with chronic renal disease |
| Q67462119 | A search for methyl urea in the blood and urine of patients with chronic renal disease |
| Q44974389 | ADMA and NOS regulation in chronic renal disease: beyond the old rivalry for l-arginine |
| Q47159336 | Abstract 30: Effect of Adipose Stromal Vascular Fraction on Random Pattern Flap Viability in Rats With Diabetes And Chronic Renal Disease: An Experimental Study |
| Q94358777 | Abstract 30: Effect of Adipose Stromal Vascular Fraction on Random Pattern Flap Viability in Rats with Diabetes and Chronic Renal Disease: An Experimental Study |
| Q53761601 | Abstract: 11.10 Effect Of Adipose Stromal Vascular Fraction On Random Pattern Flap Viability In Rats With Diabetes And Chronic Renal Disease: An Experimental Study. |
| Q94363190 | Abstract: 11.10 Effect of Adipose Stromal Vascular Fraction on Random Pattern Flap Viability in Rats with Diabetes and Chronic Renal Disease: An Experimental Study: Erratum |
| Q24795391 | Active collaboration with primary care providers increases specialist referral in chronic renal disease |
| Q70058803 | Acute and chronic effects of sulindac on renal function in chronic renal disease |
| Q43727317 | Acute and chronic renal disease in hospitalized AIDS patients |
| Q70624342 | Acute effects of oral glucose loading on the renin-angiotensin-aldosterone system in patients with chronic renal disease |
| Q101219788 | Acute kidney injury and multivessel percutaneous coronary interventions in chronic renal disease: the AMICI study |
| Q71009682 | Acute upper gastrointestinal hemorrhage and chronic renal disease |
| Q70993235 | Acute upper gastrointestinal hemorrhage in patients with chronic renal disease |
| Q79835063 | Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia |
| Q38816400 | Advances in Ethical, Social, and Economic Aspects of Chronic Renal Disease in Bolivia |
| Q69446759 | Alterations in renal tubular sodium and water reabsorption in chronic renal disease in man |
| Q67968107 | Aluminum accumulation in patients with chronic renal disease |
| Q34789716 | Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance |
| Q71010046 | Amino acid metabolism in chronic renal disease (author's transl) |
| Q89910711 | An Interaction Between Glecaprevir, Pibrentasvir, and Colchicine Causing Rhabdomyolysis in a Patient With Chronic Renal Disease |
| Q28323188 | An automated technique for the analysis of plasma guanidino acids, and some findings in chronic renal disease |
| Q68757608 | An experimental model of chronic renal disease in dogs by infusion of microspheres into the renal arterial circulation |
| Q70405352 | An investigation of biochemical and radiographic signs of hyperparathyroidism in chronic renal disease |
| Q34394499 | Anaemia in chronic renal disease: lessons learned since Seville 1994. |
| Q34220247 | Anaesthetic management of giant phaeochromocytoma in a patient with chronic renal disease |
| Q69996240 | Analgesic Abuse, Anemia and Chronic Renal Disease |
| Q74110567 | Analgesic nephropathy, a form of chronic renal disease |
| Q69759043 | Analgesic use and chronic renal disease |
| Q72660878 | Analgesic use and chronic renal disease in patients with headache |
| Q95445410 | Anemia Of Chronic Renal Disease |
| Q85011449 | Anemia in chronic renal disease: evaluation of inflammatory activity on erythropoiesis and iron metabolism in patients not submitted to dialysis treatment |
| Q69903600 | Anemia in chronic renal disease: ferrokinetic aspect of renal anemia |
| Q80524734 | Anemia management in patients with chronic renal disease: current recommendations |
| Q36547312 | Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists |
| Q38043892 | Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association? |
| Q69573850 | Angiography in Chronic Renal Disease |
| Q69401907 | Angiography in chronic renal disease and renal failure |
| Q67748436 | Angiotensin II metabolism and blood pressure in chronic renal disease |
| Q33592913 | Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future |
| Q35689572 | Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues |
| Q30387621 | Another nightmare after SARS: knowledge perceptions of and overcoming strategies for H1N1 influenza among chronic renal disease patients in Hong Kong. |
| Q45729787 | Antibodies to hepatitis C virus in patients with chronic renal disease in Sri Lanka |
| Q74299116 | Antihypertensive therapy and progression of chronic renal disease |
| Q57703144 | Antihypertensive therapy in chronic renal disease |
| Q73818006 | Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents? |
| Q28201051 | Antiproteinuric effect of niceritrol, a nicotinic acid derivative, in chronic renal disease with hyperlipidemia: a randomized trial |
| Q72334253 | Apocrine cystic calcinosis in dogs and its relationship to chronic renal disease |
| Q43536981 | Arterial calcifications in severe chronic renal disease and their relationship to dialysis treatment, renal transplant, and parathyroidectomy |
| Q57315754 | Arylsulphatase A Pseudodeficiency (ARSA-PD), hypertension and chronic renal disease in Aboriginal Australians |
| Q47665127 | Assessment of Quality of Sleep and its Relationship with Psychiatric Morbidity and Socio-Demographic Factors in the Patients of Chronic Renal Disease Undergoing Hemodialysis. |
| Q92332712 | Assessment of iron-restricted erythropoiesis in chronic renal disease: evaluation of Abbott CELL-DYN Sapphire mean reticulocyte hemoglobin content (MCHr) |
| Q93027896 | Association between neutrophil gelatinase-associated lipocalin (NGAL) and iron profile in chronic renal disease |
| Q96116151 | Association of serum levels of secreted frizzled-related protein 5 and Wnt member 5a with glomerular filtration rate in patients with type 2 diabetes mellitus and chronic renal disease: a cross-sectional study |
| Q73402506 | Avascular necrosis of the femoral head in children with chronic renal disease |
| Q72326010 | Bacteriuria and chronic renal disease |
| Q24235205 | Blood pressure targets for hypertension in patients with chronic renal disease |
| Q46378094 | Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial |
| Q41101751 | Bone lead measurements in patients with chronic renal disease studied over time |
| Q40974594 | Bone loss in patients with chronic renal disease: prediction with quantitative bone scintigraphy with SPECT |
| Q33220424 | Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism |
| Q67696926 | Brown nail arc in chronic renal disease |
| Q70339621 | Brown nail-bed arcs and chronic renal disease |
| Q78524242 | CHRONIC RENAL DISEASE AND PREGNANCY |
| Q75453016 | CLINICO-PATHOLOGIC conference; chronic renal disease due to congenital anomaly |
| Q98718826 | COVID-19 & Chronic Renal Disease: Clinical characteristics & prognosis |
| Q69670261 | CT appearance of large sternoclavicular calcific masses in a teenager with chronic renal disease and secondary hyperparathyroidism, on hemodialysis maintenance |
| Q66882766 | Calcitonin Levels in Chronic Renal Disease |
| Q69596705 | Canine chronic renal disease: prevalence and types of glomerulonephritis in the dog |
| Q69906801 | Captopril slows the progression of chronic renal disease in partially nephrectomized rats |
| Q68629293 | Captopril, but not diltiazem, favorably affects the course of early chronic renal disease in rats |
| Q71610303 | Carbonic anhydrase I and II levels in erythrocytes of chronic renal disease patients |
| Q57956731 | Cardiovascular complications of chronic renal disease |
| Q47592629 | Cardiovascular disease and chronic renal disease: a new paradigm |
| Q77752177 | Cardiovascular disease in chronic renal disease |
| Q49793966 | Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients |
| Q36161264 | Cardiovascular risk in chronic renal disease and transplantation prevention and management |
| Q81082533 | Cardiovascular risk in diabetic kidney disease: a model of chronic renal disease |
| Q70601959 | Case report 279. Secondary hyperparathyroidism related to chronic renal disease with erosion of articular surface of both patellae |
| Q98306439 | Case reports of hypercalcemia and chronic renal disease due to cosmetic injections of polymethylmethacrylate (PMMA) |
| Q31922493 | Cause and management of heart failure in patients with chronic renal disease |
| Q33991001 | Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression |
| Q39658150 | Central vertebral end-plate depression in chronic renal disease: report of two cases |
| Q85017385 | Characteristics of patients registered with chronic renal disease in Castilla y León and survival analysis of transplanted patients and their grafts |
| Q28203051 | Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life |
| Q87458657 | Children with chronic renal disease undergoing dialysis or conservative treatment--differences in structural and functional echocardiographic parameters |
| Q36473184 | Children's and young people's experiences of chronic renal disease: a review of the literature, methodological commentary and an alternative proposal. |
| Q112888223 | Chronic Kidney Disease and its Clinical Implications on Red Blood Cell Survival and Glycaemic Control |
| Q80524743 | Chronic Renal Disease Associated with HIV Infection |
| Q68961562 | Chronic Renal Disease Program |
| Q57396329 | Chronic Renal Disease and Cardiovascular Risk |
| Q94226401 | Chronic Renal Disease in the Insane |
| Q55606605 | Chronic Renal Disease in the Insane. |
| Q40853195 | Chronic Renal Disease with Bony Changes |
| Q68860766 | Chronic effects of oral sulindac on renal haemodynamics and hormones in subjects with chronic renal disease |
| Q90576099 | Chronic renal disease among lead-exposed workers |
| Q70924565 | Chronic renal disease and analgesic abuse |
| Q93375764 | Chronic renal disease and antenatal care |
| Q44396626 | Chronic renal disease and atrial fibrillation in patients with chronic heart failure |
| Q73520398 | Chronic renal disease and cardiovascular complications: inevitable or preventable? Now is the time for some intervention studies |
| Q40548834 | Chronic renal disease and growth in childhood |
| Q54128853 | Chronic renal disease and heavy use of analgesics. |
| Q70046640 | Chronic renal disease and hyperparathyroidism: dental manifestations and management |
| Q52272460 | Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. |
| Q35422516 | Chronic renal disease and potassium depletion in cats |
| Q47875750 | Chronic renal disease and pregnancy outcome |
| Q37948994 | Chronic renal disease and pregnancy. |
| Q48607745 | Chronic renal disease and reversible posterior leukoencephalopathy syndrome after liver transplantation |
| Q38239424 | Chronic renal disease and risk of cardiovascular morbidity-mortality |
| Q82787772 | Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk |
| Q46254888 | Chronic renal disease as cardiovascular risk factor |
| Q69578056 | Chronic renal disease following pregnancy and terminating with severe frontal headaches, blurred vision, confusion and stiff neck |
| Q69965491 | Chronic renal disease in Israel. Validity of death certificates |
| Q81608174 | Chronic renal disease in Kuwaiti nationals: a prospective study during the past 4 years |
| Q71569663 | Chronic renal disease in Maine |
| Q68821208 | Chronic renal disease in Polynesians in New Zealand |
| Q46869582 | Chronic renal disease in a captive two-toed sloth (Choloepus didactylus) with concurrent hepatocellular carcinoma |
| Q69717125 | Chronic renal disease in bull terriers |
| Q72139131 | Chronic renal disease in childhood |
| Q54651906 | Chronic renal disease in childhood: doubts, hopes and expectations. |
| Q70192321 | Chronic renal disease in children |
| Q74006126 | Chronic renal disease in children |
| Q51349377 | Chronic renal disease in children aged 5-18 years: a population-based survey in Turkey, the CREDIT-C study. |
| Q78309801 | Chronic renal disease in children; correlation of clinical findings with morphologic characteristics seen by light and electron microscopy |
| Q36670276 | Chronic renal disease in pregnancy |
| Q67065880 | Chronic renal disease in pregnancy |
| Q61850119 | Chronic renal disease in pregnancy; a modern approach to predicting outcome |
| Q40293150 | Chronic renal disease in rats following a temporary deficiency of potassium. |
| Q45958500 | Chronic renal disease in renal transplant patients: management of cardiovascular risk factors. |
| Q50049637 | Chronic renal disease in spain: prevalence and related factors in persons with diabetes mellitus older than 64 years |
| Q51246248 | Chronic renal disease is associated with stroke and thromboembolism in atrial fibrillation independently from gender. |
| Q33390187 | Chronic renal disease is more prevalent in patients with hemolytic uremic syndrome who had a positive history of diarrhea |
| Q40300346 | Chronic renal disease is not chronic kidney disease: implications for use of the QRISK and Joint British Societies risk scores. |
| Q34419920 | Chronic renal disease patients with severe star fruit poisoning: hemoperfusion may be an effective alternative therapy |
| Q38129584 | Chronic renal disease progression: treatment strategies and potassium intake |
| Q73839330 | Chronic renal disease with secondary hyperparathyroidism |
| Q75694298 | Chronic renal disease with secondary hyperparathyroidism |
| Q78500557 | Chronic renal disease with secondary hyperparathyroidism |
| Q33669365 | Chronic renal disease, myotonic dystrophy, and gonadoblastoma in XY gonadal dysgenesis. |
| Q73794503 | Chronic renal disease: a growing problem |
| Q44667295 | Chronic renal disease: a socio-economic study |
| Q40409252 | Chronic renal disease: do metalloproteinase inhibitors have a demonstrable role in extracellular matrix accumulation? |
| Q72080286 | Chronic renal disease: new therapies to delay kidney replacement |
| Q40966812 | Chronic renal disease: the mother's experience. |
| Q83431568 | Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism - results of a small-scale, prospective, observational study |
| Q28361053 | Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease |
| Q69952629 | Clinical and laboratory features of patients with chronic renal disease at the start of dialysis |
| Q68033833 | Clinical significance of serum and urinary neopterins in patients with chronic renal disease |
| Q47397357 | Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). |
| Q71194291 | Coagulation factor XIII in patients with acute and chronic renal disease |
| Q38539311 | Cognitive function and exercise training for chronic renal disease patients: A literature review |
| Q47100240 | Cognitive impairment of patients with chronic renal disease on hemodialysis and its relationship with sociodemographic and clinical characteristics. |
| Q85939909 | Coma associated with nelarabine in an elderly patient with T-cell acute lymphoblastic leukemia and severe chronic renal disease |
| Q81072208 | Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: new therapeutic world beyond blood pressure reduction |
| Q36033383 | Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications |
| Q42023651 | Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats. |
| Q33679948 | Comparative palatability of five supplements designed for cats suffering from chronic renal disease |
| Q86811838 | Comparison of serum cystatin C and creatinine levels in determining glomerular filtration rate in children with stage I to III chronic renal disease |
| Q87440689 | Competition for organic anion transporters in chronic renal disease |
| Q77732499 | Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here? Special report from the National Kidney Foundation Task Force on Cardiovascular Disease |
| Q74157825 | Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease |
| Q77573690 | Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease |
| Q77573704 | Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? |
| Q40501382 | Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography |
| Q36961589 | Coronary intervention in patients with diabetes, chronic renal disease, and the elderly: therapeutic implications |
| Q46938850 | Correlation between creatinine clearance and transtubular potassium concentration gradient in old people and chronic renal disease patients. |
| Q56503150 | Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease |
| Q82836442 | Cost implication of team-based structured versus usual care for type 2 diabetic patients with chronic renal disease |
| Q41660066 | Counselling patients and their families in a chronic renal disease program |
| Q34335028 | Craniofacial brown tumor as a result of secondary hyperparathyroidism in chronic renal disease patient: A rare entity |
| Q37150602 | Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes |
| Q93490062 | Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes |
| Q50951248 | Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. |
| Q84909270 | DIAGNOSIS AND PROGNOSIS IN CHRONIC RENAL DISEASE: The Range of Urea Concentration or Range of Function Test |
| Q78342893 | DWARFISM AND RICKETS IN THE COURSE OF CHRONIC RENAL DISEASE (CASE REPORT) |
| Q34660757 | Deaths from chronic renal disease in U.S. battery and lead production workers |
| Q74141680 | Dental radiographic changes in chronic renal disease |
| Q34154252 | Depression in patients with chronic renal disease: what we know and what we need to know |
| Q51895918 | Depression in patients with chronic renal disease: where are we going? |
| Q55264533 | Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol |
| Q79813753 | Desmopressin : safety considerations in patients with chronic renal disease |
| Q91929085 | Detection of Coagulopathy in Chronic Renal Disease using Thromboelastography and its comparison with Conventional Tests |
| Q40971664 | Determinants and prevalence of depression in patients with chronic renal disease, and their caregivers |
| Q95489802 | Determination of identifier factors for prioritization of kidney transplantation candidates in patients with chronic renal disease |
| Q39786806 | Development and progression of chronic renal disease: can it be prevented or attenuated? |
| Q53086965 | Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD. |
| Q70614258 | Development of chronic renal disease in cats fed a commercial diet |
| Q37171950 | Developmental origins of chronic renal disease: an integrative hypothesis. |
| Q69787936 | Diagnostic Significance of Bone Marrow Biopsy in Chronic Renal Disease |
| Q67522426 | Diamine oxidase (histaminase) in chronic renal disease and its inhibition in vitro by methylguanidine |
| Q74037960 | Diet and chronic renal disease |
| Q47890284 | Diet in chronic renal disease: a focus on calories |
| Q72119896 | Dietary management in chronic renal disease |
| Q70851832 | Dietary management of chronic renal disease |
| Q35626373 | Dietary mobile apps and their effect on nutritional indicators in chronic renal disease: a systematic review. |
| Q33762978 | Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. |
| Q73957497 | Dietary protein restriction in combination with angiotensin converting enzyme inhibitor improves insulin resistance in patients with chronic renal disease |
| Q74732123 | Direct method for the measurement of low-density lipoprotein cholesterol levels in patients with chronic renal disease: a comparative assessment |
| Q43612105 | Disturbances of calcium/phosphorus metabolism in chronic renal disease |
| Q64950800 | Diuretics in chronic renal disease: a study of high dosage frusemide. |
| Q34371310 | Does growth retardation indicate suboptimal clinical care in children with chronic renal disease and those undergoing dialysis? |
| Q112906764 | Drug dosing in the elderly: the impact of age and tubular function |
| Q35916485 | Dual blockade of the renin-angiotensin system in chronic renal disease: to do or not to do. |
| Q58947188 | Dyslipidemia in Chronic Renal Disease |
| Q76925337 | EVALUATION AND MANAGEMENT OF CHRONIC RENAL DISEASE |
| Q95608415 | Early detection of chronic renal disease |
| Q92266008 | Early detection of chronic renal disease: coordinated work between primary and specialized care in an ambulatory renal network of Peru |
| Q79045795 | Early diagnosis in chronic renal disease |
| Q67727908 | Early radiographic manifestations of secondary hyperparathyroidism associated with chronic renal disease |
| Q79959668 | Earnings and chronic renal disease |
| Q91730281 | Echocardiographic assessment of cardiac structure and function in chronic renal disease |
| Q89244459 | Economic Implications Of Chronic Renal Disease With And Without Co-Morbid Diabetes In China, Post-2005 |
| Q72851976 | Effect of 1,25-(OH)2D3 on jejunal absorption of magnesium in patients with chronic renal disease |
| Q67341742 | Effect of 25-hydroxycholecalciferol on calcium absorption in chronic renal disease |
| Q73598695 | Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials |
| Q69808148 | Effect of clonidine on the progression of chronic renal disease in partially nephrectomized rats |
| Q68112744 | Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease |
| Q74335101 | Effect of hypotensive drugs on renal function in chronic renal disease |
| Q69432807 | Effect of propranolol on progression of chronic renal disease in partially nephrectomized rats |
| Q47933241 | Effect of renal transplantation for chronic renal disease on left ventricular mass |
| Q112931442 | Effectiveness and safety of vitamin D compounds in people with chronic kidney disease: A systematic review and meta-analysis |
| Q43962802 | Effects of Atrial Natriuretic Peptide (99-126) in Chronic Renal Disease in Man |
| Q36031155 | Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial |
| Q44477225 | Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above |
| Q44510474 | Effects of chronic renal disease on the transport of vitamin A in plasma and urine of dogs |
| Q67021216 | Effects of chronic renal disease on thyroid hormone metabolism |
| Q67943076 | Efficacy of the combination of nicardipine-enalapril and atenolol in severe hypertension secondary to chronic renal disease |
| Q84948219 | Electrocardiography in the diagnosis of ventricular hypertrophy in patients with chronic renal disease |
| Q78910486 | Electrolyte disorders in chronic renal disease |
| Q79429899 | Endogenous creatinine clearance. A valuable clinical test of glomerular filtration and a prognostic guide in chronic renal disease |
| Q33778006 | Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse |
| Q53358959 | Endothelin-1, big endothelin-1, and nitric oxide in patients with chronic renal disease and hypertension. |
| Q101408504 | Enterococcus casseliflavus Bacteraemia in a Patient with Chronic Renal Disease |
| Q68594853 | Enzyme content of casts in chronic renal disease |
| Q46841634 | Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study |
| Q45143419 | Epidemiology of chronic renal disease in the North-West of Russia: setting-up the register |
| Q39091911 | Epidemiology of sleep disorders in patients with chronic renal disease in Cairo, Egypt |
| Q43071288 | Eplerenone in chronic renal disease: the EVALUATE trial |
| Q84309035 | Erratum to: Dual blockade of the renin-angiotensin system in chronic renal disease: to do or not to do |
| Q71666315 | Erythrocyte Glutathione Reductase Activity in Chronic Renal Disease |
| Q68490830 | Erythrocyte membrane ATPase in patients with acute or chronic renal disease |
| Q69036664 | Erythrocyte transketolase activity in patients with chronic renal disease |
| Q70066431 | Erythropoiesis in chronic renal disease |
| Q43597059 | Erythropoietin in serum and urine in healthy persons and patients with chronic renal disease upon hypoxic stimulation and hypoxic stimulation after pretreatment with fluoxymesterone (author's transl) |
| Q70284664 | Erythropoietin production in chronic renal disease before and after transplantation |
| Q72130385 | Evaluation of chronic renal disease in heart transplant recipients: importance of pretransplantation native kidney histologic evaluation |
| Q71616463 | Evaluation of neurologic dysfunction in children with chronic renal disease by neurometrics |
| Q92559622 | Evaluation of the effects of aerobic training during hemodialysis on autonomic heart rate modulation in patients with chronic renal disease |
| Q74310116 | Excessive dietary protein and suboptimal caloric intake have a negative effect on the growth of children with chronic renal disease before and during growth hormone therapy |
| Q70073589 | Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction |
| Q72037142 | Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction |
| Q74460720 | Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype |
| Q71575642 | Factor VIII activity in chronic renal disease |
| Q46692151 | Failure of vitamin E to prevent placental changes and abruptio placentae in guinea pigs treated with oestrogens and in women suffering from hypertension, chronic renal disease or toxaemia of pregnancy |
| Q70670567 | Fat-soluble vitamin nutrition in patients with chronic renal disease |
| Q51415590 | Features of chronic renal disease in children. |
| Q53645149 | Features of chronic renal disease in children. |
| Q72236452 | Ferrokinetics in Patients Suffering from Chronic Renal Disease and Anaemia |
| Q73409758 | Fetal hemoglobin in patients with chronic renal disease |
| Q70790699 | Fluorescent substance(s) in serum and urine of patients with chronic renal disease |
| Q71751408 | Food for Thought in Chronic Renal Disease |
| Q83085295 | Free water clearance: its behavior in chronic renal disease at different ages |
| Q71490124 | Functional role of endogenous adenosine in human chronic renal disease |
| Q67338437 | General and regional hemodynamics in hypertension in chronic renal disease |
| Q82800967 | Giant cell arteritis; chronic renal disease |
| Q72343947 | Glomerular filtration rate. Determination in patients with chronic renal disease |
| Q70572975 | Glutathione, glutathione reductase and glutathione S-transferase activities in erythrocytes and lymphocytes in chronic renal disease |
| Q63683441 | Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population |
| Q33552662 | Gout secondary to chronic renal disease: studies on urate metabolism |
| Q81099294 | Growth in children with chronic renal disease |
| Q68870772 | Growth retardation in children with chronic renal disease: scope of the problem |
| Q73923531 | Guiding lights for antihypertensive treatment in patients with nondiabetic chronic renal disease: proteinuria and blood pressure levels? |
| Q67653223 | Haemodynamics of hypertension in chronic renal disease |
| Q95358870 | Half and half nails (Lindsay's nails) in chronic renal disease |
| Q60032015 | Hantavirus-specific IgG, IgM, and IgA in acute and chronic renal disease versus congenital renal disease in the United States |
| Q72123019 | Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients |
| Q84589690 | Heart rate recovery after exercise is associated with renal function in patients with a homogenous chronic renal disease |
| Q70992674 | Hemodialysis clearance of ethosuximide in patients with chronic renal disease |
| Q89585442 | Hemodialysis improves skin moisture and sebum secretion but not elasticity in chronic renal disease patients |
| Q47891793 | Hemoglobin affinity for oxygen in chronic renal disease: the effect of hemodialysis. |
| Q43899234 | Hepatitis B surface antigen is not associated with chronic renal disease in aboriginal Australians |
| Q90602898 | Hepatitis C virus infection and chronic renal disease: A review |
| Q104287224 | Hepatocellular carcinoma in patients with chronic renal disease: Challenges of interventional treatment |
| Q53427950 | History of dietary protein therapy for the treatment of chronic renal disease from the mid 1800s until the 1950s. |
| Q23918700 | Hydrocarbon exposure and chronic renal disease |
| Q77573748 | Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease |
| Q77573739 | Hyperlipidemia in patients with chronic renal disease |
| Q70319047 | Hyperoxaluria in chronic renal disease associated with spinal cord injury |
| Q71478214 | Hypertension in chronic renal disease |
| Q77573735 | Hypertension in patients with chronic renal disease |
| Q71787118 | Hyperuricemia and chronic renal disease |
| Q72041525 | Hyperuricemia and urate excretion in chronic renal disease |
| Q67272571 | Hypomagnesemia and Impaired Parathyroid Hormone Secretion in Chronic Renal Disease |
| Q73017596 | Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease |
| Q28574673 | IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease |
| Q77228378 | INFLUENCE OF DIETARY SODIUM ON RENAL FUNCTION IN PATIENTS WITH CHRONIC RENAL DISEASE |
| Q69321135 | Identical twins discordant for chronic renal disease |
| Q37739880 | Imaging chronic renal disease and renal transplant in children |
| Q70072361 | Immunosuppressive drugs and chronic renal disease |
| Q83182869 | Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation |
| Q46984191 | Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. |
| Q102208562 | Impaired Reconversion of Bone Marrow in Nuclear Magnetic Resonance in Patients with Chronic Renal Disease |
| Q34973959 | Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach |
| Q41929180 | Improved neurological outcome in children with chronic renal disease from infancy |
| Q72524171 | Improvement of renal function with prostaglandin E1 infusion in patients with chronic renal disease |
| Q46023332 | Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism. |
| Q42107723 | Incidence, mortality, and prevalence of end-stage chronic renal disease in the Bajo Lempa region of El Salvador: A ten-year community registry |
| Q70220106 | Increased Serum Angiotensin-Converting Enzyme in Chronic Renal Disease |
| Q83412682 | Increased cardiac troponin T levels are related to inflammatory markers and various indices of renal function in chronic renal disease patients |
| Q72438968 | Increased proteinuria due to steroid therapy in chronic renal disease |
| Q93842662 | Increased proteinuria due to steroid therapy in chronic renal disease |
| Q80213421 | Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA) |
| Q41271089 | Infantilism with Polyuria and Chronic Renal Disease |
| Q43155405 | Inflammation and insulin resistance: chronic renal disease features |
| Q36264531 | Inflammatory Markers and Procoagulants in Chronic Renal Disease Stages 1-4. |
| Q36204524 | Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome |
| Q57599586 | Influence of early dialysis among patients with advanced chronic renal disease: results of a systematic review |
| Q45954219 | Iniquities in the access to renal transplant for patients with end-stage chronic renal disease in Brazil. |
| Q34495255 | Insights into the abnormalities of chronic renal disease attributed to malnutrition |
| Q37049390 | Interactions between chronic renal disease and periodontal disease |
| Q68601271 | Intestinal calcium absorption: nature of defect in chronic renal disease |
| Q84495711 | Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease |
| Q67319700 | Investigations on latent erythropoietin (ESF) deficiency in non anemic patients with chronic renal disease using hypoxic stimulation methods |
| Q74579517 | Involvement of nitric oxide synthase in proteinuria associated with chronic renal disease in rats |
| Q71425286 | Iron Absorption in Chronic Renal Disease |
| Q67601694 | Iron accumulation in human chronic renal disease |
| Q69571611 | Is chronic renal disease always progressive? |
| Q37832766 | Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD? |
| Q30559037 | Isaac Albeniz (1860-1909): Spanish musician who died of chronic renal disease |
| Q70460163 | Isolation and chromatographic analysis of unidentified fluorescence in biological fluids of patients with chronic renal disease |
| Q86480073 | Isoniazid Induced Metabolic Acidosis and Renal Dysfunction in an Elderly Patient with Chronic Renal Disease |
| Q74293445 | Isotope investigations of red cell production and destruction in chronic renal disease |
| Q34464954 | Jejunal Absorption and Secretion of Calcium in Patients with Chronic Renal Disease on Hemodialysis |
| Q71038806 | Keratotic papules in chronic renal disease |
| Q87432349 | Left ventricular mass and cardiothoracic index in patients with chronic renal disease on hemodialysis |
| Q67546377 | Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation |
| Q72242089 | Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease |
| Q68025037 | Lipoproteins and apolipoproteins during the progression of chronic renal disease |
| Q44929256 | Lower incidence of death from chronic renal disease in patients with nonlethal emphysema: a statistical study |
| Q95810701 | METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE |
| Q35201402 | Magnesium absorption in the human small intestine. Results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria |
| Q73759387 | Management of chronic renal disease |
| Q44362358 | Management of hyperphosphataemia in chronic renal disease: lessons from the past and future directions |
| Q67352057 | Management of hypertension in the patient with chronic renal disease |
| Q66847658 | Management of orofacial infection in patients with chronic renal disease |
| Q69892781 | Managing hypertension in chronic renal disease |
| Q67933575 | Measures of renal function in patients with cisplatin-related chronic renal disease |
| Q71775305 | Medical management of chronic renal disease |
| Q40992534 | Medicare Coverage for Chronic Renal Disease: Policy Implications |
| Q74762847 | Medicare coverage for chronic renal disease: policy implications |
| Q69814568 | Metabolic studies on red cells from patients with chronic renal disease on haemodialysis |
| Q53986339 | Metabolic studies on the erythrocyte from patients with chronic renal disease on haemodialysis. II. ATP metabolism. |
| Q86395639 | Metabolic syndrome is a risk factor for the development of chronic renal disease |
| Q72125547 | Methadone use in patients with chronic renal disease |
| Q51910849 | Microalbuminuria, chronic renal disease, and the effects of the metabolic syndrome on cardiovascular events. |
| Q33490496 | Microvascular thrombosis in the pathogenesis of chronic renal disease |
| Q85215898 | Molecular mechanism of proteinuria caused progression of chronic renal disease |
| Q70895016 | Morning glory optic disc anomaly associated with chronic renal disease |
| Q91350015 | Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy |
| Q64042540 | Multidisciplinary approach for patients with nephropathic cystinosis: model for care in a rare and chronic renal disease |
| Q42271394 | Multiple brown tumors as a result of hyperparathyroidism in chronic renal disease: a case report |
| Q70570213 | Multiple cysts in chronic renal disease |
| Q77968435 | Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1,850 biopsied cases. Research Group on Progressive Chronic Renal Disease |
| Q39761329 | Naturally-occurring chronic renal disease in Australian cats: a prospective study of 184 cases |
| Q49228517 | Nephrotic Syndrome and Chronic Renal Disease in the Tropics |
| Q59459535 | Neurodevelopmental Issues in Chronic Renal Disease |
| Q87025454 | Neurofibromas of the bladder in a child with neurofibromatosis type 1 causing chronic renal disease |
| Q68657698 | Neuropathy in chronic renal disease |
| Q82568595 | Nitric oxide suppresses EPO-induced monocyte chemoattractant protein-1 in endothelial cells: implications for atherogenesis in chronic renal disease |
| Q43413065 | No association between perception of family functioning and treatment modality for chronic renal disease secondary to diabetes mellitus |
| Q41149758 | Nutrition and chronic renal disease in children. |
| Q34273984 | Nutritional management of chronic renal disease |
| Q36645088 | Nutritional management of chronic renal disease in dogs and cats |
| Q74087727 | Nutritional status and amino acids in granulocytes and plasma in patients with chronic renal disease and varying residual renal function |
| Q80143476 | Nutritional supplements to be covered in Pa. by Chronic Renal Disease Program |
| Q90046231 | Obesity and bariatric intervention in patients with chronic renal disease |
| Q50081043 | Obesity and renal function. Data from the epidemiological study: Prevalence of chronic renal disease in Spain. EPIRCE Study |
| Q68947415 | Ocular complications of chronic renal disease |
| Q73832374 | Odour perception in chronic renal disease |
| Q93910286 | Odour perception in chronic renal disease |
| Q77573700 | On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes |
| Q35635777 | On the mechanism of acidosis in chronic renal disease |
| Q53861205 | On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake |
| Q72302815 | On the progression of chronic renal disease |
| Q74723601 | Osteosclerosis in chronic renal disease |
| Q104757935 | Otorhinolaryngologic, head and neck presentations among patients with chronic renal disease in a developing country |
| Q82997277 | Outcome predictors of chronic renal disease patients with parapneumonic empyemas |
| Q38612147 | Overview of anemia associated with chronic renal disease: primary and secondary mechanisms |
| Q44126001 | Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication |
| Q69056371 | Oxygen Binding to Haemoglobin in Subjects with Hypoproliferative Anaemia, with and without Chronic Renal Disease: Role of pH |
| Q76783773 | PREGNANCY AND CHRONIC RENAL DISEASE |
| Q78330037 | PROLONGED ADMINISTRATION OF ETHACRYNIC ACID IN PATIENTS WITH CHRONIC RENAL DISEASE |
| Q78396121 | PROTEIN requirements in chronic renal disease |
| Q90792851 | Paget disease of bone in an elderly patient with chronic renal disease and weight loss: A case report |
| Q46550791 | Parathyroid hormone (PTH) metabolism in chronic renal disease (CRD) |
| Q28240759 | Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease |
| Q74657788 | Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease |
| Q73233925 | Pathologic quiz case: a 38-year-old woman with chronic renal disease and dyspnea |
| Q35581985 | Patient and disease characteristics associated with activation for self-management in patients with diabetes, chronic obstructive pulmonary disease, chronic heart failure and chronic renal disease: a cross-sectional survey study |
| Q68691706 | Perception of illness and depression in chronic renal disease |
| Q61447163 | Perioperative acute myocardial infarction rate in chronic renal disease patients undergoing orthopedic surgery: Is there any difference between dialyzed and nondialyzed patients? |
| Q46244840 | Perioperative renal functions in patients with chronic renal disease |
| Q70856738 | Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy |
| Q68819364 | Pharmacokinetics of oral propranolol in chronic renal disease |
| Q70670037 | Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease |
| Q68128151 | Pharmacological and dietary intervention in experimental models of chronic renal disease |
| Q84787531 | Phosphorus and calcium metabolism and the cardiovascular system status in patients with early-stage chronic renal disease |
| Q97872645 | PhysIOpathology of NEuromuscular function rElated to fatigue in chronic Renal disease in the elderly (PIONEER): study protocol |
| Q68951078 | Physical work capacity in chronic renal disease |
| Q72205998 | Pitressin-resistant hyposthenuria in chronic renal disease |
| Q70233120 | Plasma aldosterone concentrations in chronic renal disease |
| Q68120379 | Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease |
| Q72184988 | Plasma fibrinolytic activity in chronic renal disease |
| Q72856259 | Plasma levels of superoxide dismutase and its isomers in patients with chronic renal disease |
| Q70379086 | Plasma oxalate concentration in chronic renal disease |
| Q73318051 | Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease |
| Q73006796 | Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis |
| Q47188147 | Pneumococcal polysaccharide vaccine in children with chronic renal disease: a prospective study of antibody response and duration |
| Q72647759 | Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients |
| Q71163534 | Pneumococcal vaccine in children and young adults with chronic renal disease |
| Q71137145 | Porphyria cutanea tarda associated with chronic renal disease and hemodialysis |
| Q47855617 | Possible other causative risk factors in patients with chronic renal disease who had a history of hemolytic uremic syndrome |
| Q37622058 | Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism |
| Q43892413 | Postmortem diagnosis of "occult" Klinefelter syndrome in a patient with chronic renal disease and liver cirrhosis |
| Q75735979 | Potassium deficiency in chronic renal disease |
| Q57717580 | Predicted Creatinine Clearance to Assess Glomerular Filtration Rate in Chronic Renal Disease in Humans |
| Q54677915 | Predicting Risk of Chronic Renal Disease in Children with Vesicoureteral Reflux-How Good or Bad are We Doing? |
| Q71355043 | Predictors of and therapeutic strategies in progressive chronic renal disease |
| Q81188321 | Preeclampsia or initial diagnosis of chronic renal disease during pregnancy |
| Q69884413 | Pregnancy in women with chronic renal disease |
| Q45122202 | Pregnancy in women with chronic renal disease: a 14-year study. |
| Q40797004 | Presence of creatine phosphokinase brain band in the serum of chronic renal disease patients |
| Q44316294 | Presentation and detection of chronic renal disease in children and adults |
| Q39376320 | Prevalence of Chronic Kidney Disease in Turkish Adults With Obesity and Metabolic Syndrome: A Post Hoc Analysis from Chronic Renal Disease in Turkey Study |
| Q86096091 | Prevalence of carotid artery calcification in patients with chronic renal disease identified by panoramic radiography |
| Q43206078 | Prevalence of chronic renal disease in Spain: results of the EPIRCE study |
| Q50673536 | Prevalence of chronic renal disease in adults attended by the family health strategy. |
| Q40940279 | Prevalence of erectile dysfunction in chronic renal disease patients on conservative treatment |
| Q38916002 | Prevalence of hantavirus antibody in patients with chronic renal disease in Egypt |
| Q50986483 | Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. |
| Q43618553 | Prevalence of occult chronic renal disease in hypertensive patients |
| Q71084219 | Preventing Influenza in Chronic Renal Disease |
| Q84033541 | Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies |
| Q80577128 | Prevention strategies for chronic kidney disease in Latin America: a strategy for the next decade. Proceedings of the First John H. Dirks Chronic Renal Disease Prevention Meeting. November 21-23, 2005. Vallarica, Chile |
| Q82251897 | Proceedings of the 8th Symposium on Growth and Nutrition in Children with Chronic Renal Disease, Symposium of the International Pediatric Nephrology Association (IPNA). Oviedo, Spain. May, 28-30, 2009 |
| Q46314034 | Program of early diagnosis of chronic renal disease in children--SopKard 15 nephrological project |
| Q68406402 | Progression of chronic renal disease |
| Q73069534 | Progression of chronic renal disease |
| Q40789525 | Progression of chronic renal disease and diabetic nephropathy: a review of clinical studies and current therapy. |
| Q49610598 | Progression of chronic renal disease in a reference hospital of social security of Peru 2012-2015 |
| Q70934864 | Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix |
| Q33787746 | Progression of chronic renal disease in the dog. |
| Q69634520 | Progression of chronic renal disease: role of systemic and glomerular hypertension |
| Q35669317 | Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. |
| Q70375935 | Prospective controlled study of androgen therapy in the anemia of chronic renal disease: effects on iron kinetics |
| Q37374585 | Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat. |
| Q37354825 | Protection of Wistar Furth Rats from Chronic Renal Disease Is Associated with Maintained Renal Nitric Oxide Synthase |
| Q24320230 | Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease |
| Q43786576 | Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate |
| Q43225544 | Proteinuria in chronic renal disease was not mentioned. |
| Q69952107 | Quantitative ultrastructure of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis) |
| Q78243433 | RETINOPATHIES OF CHRONIC RENAL DISEASE; REVERSALS AFTER RENAL TRANSPLANTATION |
| Q78877025 | Radioisotopic Study of Anemia in Chronic Renal Disease |
| Q43935605 | Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria |
| Q66858507 | Rational nursing care in chronic renal disease |
| Q69191701 | Recent advances in the management of chronic renal disease |
| Q67599271 | Recombinant human growth hormone in pubertal patients with chronic renal disease |
| Q68635022 | Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report on five European studies |
| Q37354841 | Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis |
| Q42552416 | Reduced progression, increased mortality in chronic renal disease after treatment with the angiotensin-converting enzyme inhibitor benazepril |
| Q74464363 | Referral for chronic renal disease: the need for a change in threshold |
| Q43649252 | Registration of patients with chronic renal disease in Trondelag county and assessment of the therapeutic need |
| Q70831991 | Rehabilitation as an integral part of nursing, with special reference to the patient with chronic renal disease |
| Q71030371 | Rehabilitation status of chronic renal disease patients undergoing dialysis: variations by age category |
| Q68089756 | Rehabilitation, aging and chronic renal disease |
| Q67825190 | Relation between creatinine clearance and glomerular filtration in various stages of chronic renal disease |
| Q68081265 | Relation of amino acids, energy levels and protein synthesis in chronic renal disease |
| Q40269900 | Relations of HLA A2, A3, B12 antigens, and A2-B12 supposed haplotype association, with latent herpes virus infection in patients with chronic renal disease (author's transl) |
| Q74408344 | Relationship between endogenous 24-hour creatinine clearance and serum creatinine concentration in patients with chronic renal disease |
| Q58760695 | Remarks on Chronic Renal Disease: Its Frequency in Asylum Necropsies, and Its Possible Connection with Alcohol as A Cause of Insanity |
| Q83053376 | Renal creatinine handling in very old patients with chronic renal disease |
| Q68674595 | Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease |
| Q46678684 | Renal potassium excretion: comparison between chronic renal disease patients and old people |
| Q70186454 | Renin and body fluid volumes in chronic renal disease. Relations between arterial pressure, plasma renin activity, blood volume, and extracellular volume in chronic renal disease, as compared with essential hypertension |
| Q72242283 | Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease |
| Q72382639 | Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease |
| Q40527171 | Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease Bethesda (MA) April 1994. |
| Q35102966 | Requirement of drug development for chronic renal disease: Other strategies than blockade of the renin-angiotensin system. |
| Q33495583 | Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin |
| Q44445107 | Retarding progression of chronic renal disease: the neglected issue of residual proteinuria |
| Q69867505 | Reversible Bullous Retinal Detachment in Chronic Renal Disease |
| Q72888088 | Reversible Insufficiency in Chronic Renal Disease |
| Q73276152 | Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease |
| Q43831302 | Rise in serum creatinine under the androgen fluoxymesterone in chronic renal disease (author's transl) |
| Q41915198 | Risk factors for development of cardiovascular complications in patients with chronic renal disease and diabetic nephropathy |
| Q72349949 | Roentgenographic manifestations of chronic renal disease treated by periodic hemodialysis |
| Q61456312 | Role of Renal Prostaglandin E 2 in Chronic Renal Disease Hypertension |
| Q74515231 | Role of dyslipidemia in the progression of chronic renal disease |
| Q73156807 | Role of lipid peroxidation, trace elements and anti-oxidant enzymes in chronic renal disease patients |
| Q66843292 | Role of the Renin-Angiotensin-Aldosterone System in the Regulation of Plasma Potassium in Chronic Renal Disease |
| Q46978383 | Role of uric acid in hypertension and in the progression of chronic renal disease |
| Q98161162 | SARS-CoV-2 infection associated acute kidney injury in patients with pre-existing chronic renal disease: A report of two cases |
| Q46706041 | Safety and effectiveness of nicotinic acid in the management of patients with chronic renal disease and hyperlipidemia associated to hyperphosphatemia |
| Q28370594 | Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease |
| Q89445734 | Salivary creatinine and urea are higher in an experimental model of acute but not chronic renal disease |
| Q71248831 | Salt therapy in pregnancy complicated by chronic renal disease |
| Q77573756 | Screening and treatment for cardiovascular disease in patients with chronic renal disease |
| Q50140355 | Secondary hyperparathyroidism in chronic renal disease - etiopathogenesis, diagnosis and treatment |
| Q41815801 | Secondary hyperparathyroidism in chronic renal disease with metastatic skin calcification. |
| Q70642698 | Secondary hyperparathyroidism in rats with an experimental chronic renal disease |
| Q66918930 | Serum Levels of Testosterone and Luteinizing Hormone in Patients with Chronic Renal Disease |
| Q66953489 | Serum Vanadium Levels in Chronic Renal Disease |
| Q71502314 | Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication |
| Q66918928 | Serum calcitonin in patients with chronic renal disease |
| Q77296993 | Serum ionized versus total magnesium in patients with chronic renal disease |
| Q95434145 | Serum small-dense LDL abnormalities in chronic renal disease patients |
| Q93666366 | Sexual consequences and problems in marital relations in patients with chronic renal disease |
| Q38270957 | Sexual dysfunction in patients with chronic renal disease: does it improve with renal transplantation? |
| Q52534973 | Significance of acute and chronic renal disease in Osborne-Mendel rats ingesting dieldrin or aldrin. |
| Q23918186 | Silicosis and chronic renal disease |
| Q79290594 | Skeletal Disproportion in Children with Chronic Renal Disease |
| Q30925326 | Skeletal Status in Patients with Chronic Renal Disease |
| Q95938440 | Sleeping Disorders and Health-Related Quality of Life in Hemodialysis Patients with Chronic Renal Disease in Greece |
| Q72960630 | Sodium homeostasis in chronic renal disease |
| Q66845003 | Sorbents in the treatment of chronic renal disease |
| Q57750514 | Special Patient Populations: Chronic Renal Disease |
| Q69450312 | State chronic renal disease service |
| Q77589047 | Steady-state trough plasma mibefradil concentrations and correlation to blood pressure response in hypertensive patients with chronic renal disease |
| Q92318582 | Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease |
| Q69885572 | Studies on the reliability of the isotopic calcium absorption test in patients with chronic renal disease |
| Q71564757 | Subdural Hematoma Associated With Long-Term Hemodialysis For Chronic Renal Disease |
| Q48602622 | Successful aging theory and the patient with chronic renal disease: application in the clinical setting. |
| Q91354483 | Sudden cardiac death in chronic renal disease: aetiology and risk reduction strategies |
| Q88746503 | Sudden death in patients with advanced chronic renal disease |
| Q67761562 | Summer holiday camp for children with chronic renal disease (author's transl) |
| Q57703869 | Sympathetic Overactivity in Hypertensive Patients with Chronic Renal Disease |
| Q34473933 | Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis |
| Q66878536 | T and B lymphocytes in patients with chronic renal disease on hemodialysis |
| Q41635446 | THE RISK OF ACUTE RENAL LESIONS AND ITS PROGNOSTIC SIGNIFICANCE IN PATIENTS WITH CHRONIC RENAL DISEASE UNDERGOING CARDIAC SURGICAL INTERVENTION |
| Q70621903 | Taste acuity and zinc status in chronic renal disease |
| Q61456309 | The 24-hour control of blood pressure in hypertension of chronic renal disease with mepindolol |
| Q56867091 | The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease |
| Q71480800 | The Function of the Exocrine Pancreas in Chronic Renal Disease |
| Q35256707 | The Hantaviruses, etiologic agents of hemorrhagic fever with renal syndrome: a possible cause of hypertension and chronic renal disease in the United States |
| Q94142346 | The Treatment of Chronic Renal Disease |
| Q71352290 | The association between chronic renal disease and cone-shaped epiphyses in children |
| Q52131898 | The association of peptic ulceration, chronic renal disease, and analgesic abuse |
| Q46720088 | The characteristics of left ventricular myocardial remodeling in patients with chronic renal disease, and the effects of spironolactone therapy |
| Q71137226 | The clinical, functional, and histologic response to heparin in chronic renal disease |
| Q78582687 | The diuretic effects of hydrochlorothiazide in congestive heart failure, cirrhosis, chronic renal disease and hypertension: preliminary report based on a study of 28 cases |
| Q36649579 | The dyslipidemia of chronic renal disease: effects of statin therapy |
| Q52922992 | The early effects of dietary restriction on the pathogenesis of chronic renal disease in Sprague-Dawley rats at 12 months. |
| Q57692160 | The effect of 5,6-trans vitamin D3 on calcium absorption in chronic renal disease |
| Q72226503 | The effect of Na2SO4 on urinary acidification in chronic renal disease |
| Q40772568 | The erythrocyte sedimentation rate, C-reactive protein, plasma fibrinogen and viscosity in chronic renal disease patients with infection |
| Q69419055 | The familial occurrence of chronic renal disease |
| Q40753379 | The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group |
| Q48623676 | The health assurance coaching model for chronic renal disease management |
| Q79333997 | The kidney and erythropoiesis with special consideration of the anemia of chronic renal disease |
| Q36207148 | The magnitude of nephron number reduction mediates intrauterine growth-restriction-induced long term chronic renal disease in the rat. A comparative study in two experimental models |
| Q73231281 | The management of chronic renal disease |
| Q73823280 | The management of chronic renal disease |
| Q72301364 | The obstetric prognosis in chronic renal disease |
| Q73424191 | The ophthalmologic aspects of chronic renal disease |
| Q43172652 | The perceptions of and disincentives for receiving influenza A (H1N1) vaccines among chronic renal disease patients in Hong Kong |
| Q67979391 | The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease |
| Q40676931 | The production of chronic renal disease in rats by a single intravenous injection of aminonucleoside of puromycin and the effect of low dosage continuous hydrocortisone. |
| Q40872604 | The progression of chronic renal disease: immunological, nutritional and intrinsic renal mechanisms |
| Q90063469 | The role of cardiac troponin T in detection of cardiac damage and long term mortality in children with chronic renal disease |
| Q81265420 | The role of dietary phosphorus restriction in the conservative management of chronic renal disease |
| Q44690005 | The role of primary physicians in the early detection and treatment of chronic renal disease: challenges and opportunities |
| Q94447052 | The role of the renin angiotensin system in chronic renal disease |
| Q68205558 | The short term effects of oral labetalol in patients with chronic renal disease and hypertension |
| Q71394785 | The unidentified fluorescent substance in serum of patients with chronic renal disease is also found in hemofiltrates, dialysis fluids, and urine |
| Q73066930 | The use of cobaltous chloride in the anemia associated with chronic renal disease |
| Q71353405 | Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease |
| Q75206088 | Therapeutic considerations for the use of statin therapy in chronic renal disease |
| Q79609865 | Three successive pregnancies in a patient with chronic renal disease progressing from chronic renal dysfunction through to institution of dialysis during pregnancy and then on to maintenance dialysis |
| Q41642944 | Thyroid function and lipids in patients with chronic renal disease treated by hemodialysis: With comments on the “free thyroxine index” |
| Q50891149 | Total Joint Arthroplasty in Patients with Chronic Renal Disease: Is It Worth the Risk? |
| Q69555773 | Total body calcium and long-term calcium balance in chronic renal disease |
| Q28344716 | Total nitric oxide production is low in patients with chronic renal disease |
| Q43295263 | Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens. |
| Q70039090 | Traumatic bilateral patellar tendon rupture with chronic renal disease |
| Q36067693 | Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists |
| Q34549650 | Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? |
| Q98202593 | Triglycerides to High-Density Lipoprotein Cholesterol Ratio Predicts Chronic Renal Disease in Patients without Diabetes Mellitus (STELLA Study) |
| Q80524729 | Tuberculosis and chronic renal disease |
| Q75969522 | Two cases of chronic renal disease simulating morbus Addison |
| Q42456765 | Ultrastructural analysis of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis). |
| Q68175161 | Unusual articular manifestations in chronic renal disease |
| Q70708698 | Unusual complication of soft tissue calcifications in chronic renal disease: the articular erosions |
| Q73302731 | Unusual forms of chronic renal disease |
| Q35563082 | Uremic malnutrition-inflammation syndrome in chronic renal disease: a pathobiologic entity |
| Q36014482 | Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease |
| Q34437061 | Urinary cytokines: clinically useful markers of chronic renal disease progression? |
| Q67995698 | Urinary dopamine excretion in chronic renal disease |
| Q28199021 | Urinary fatty acid binding protein as a new clinical marker for the progression of chronic renal disease |
| Q29040146 | Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease |
| Q68318519 | Urinary kallikrein excretion in chronic renal disease with respect to salt intake and renal reserve |
| Q71278319 | Urinary prostaglandin E2 excretion in chronic renal disease |
| Q61456319 | Urinary prostaglandin E2 in chronic renal disease |
| Q70723350 | Urinary prostaglandin-E2 in chronic renal disease |
| Q73318655 | Use of artificial kidney in chronic renal disease |
| Q72090703 | Use of dietary sodium in treatment of patients with chronic renal disease |
| Q79002085 | Use of renal biopsy to predict the clinical result of hemodialysis in chronic renal disease |
| Q35195450 | Value of renal cortical thickness as a predictor of renal function impairment in chronic renal disease patients |
| Q79909196 | Vascular changes in chronic renal disease patients with secondary hyperparathyroidism |
| Q72381738 | Vasopressin-resistant hyposthenuria in advanced chronic renal disease |
| Q34080265 | Vitamin D therapy in patients with chronic renal disease: the role of the renal dietitian |
| Q45026119 | Vitamin D: synthesis, metabolism, regulation, and an assessment of its deficiency in patients with chronic renal disease |
| Q76013497 | WEEKLY clinicopathological exercises: parathyroid adenoma (and chronic renal disease) |
| Q70817928 | Xeroradiographic observations in four patients with chronic renal disease and cutaneous gangrene |
| Q85649475 | [Antiatherogenic and nephroprotective efficacy of atorvastatin in patients with chronic renal disease of non-diabetic origin] |
| Q68839002 | [Antihypertensive drugs for patients with chronic renal disease] |
| Q80239120 | [Are specific pre-dialysis clinical visit necessary? Objective: comprehensive care of patients with chronic renal disease (CRD)] |
| Q87090248 | [Association between obesity and chronic renal disease] |
| Q84290516 | [Cardiovascular disease, renal disease and other chronic diseases. Earlier intervention is needed in chronic renal disease] |
| Q51211045 | [Chronic renal disease and dialysis in China]. |
| Q80002769 | [Chronic renal disease and gravidity--case study] |
| Q79291992 | [Chronic renal disease and mortality] |
| Q51200151 | [Chronic renal disease in Puerto Rico: incidence, prevalence, and mortality in 2000-2008]. |
| Q80085638 | [Chronic renal disease in boys with posterior urethral valve] |
| Q51482169 | [Chronic renal disease in diabetic and prediabetic subjects: a community-based study in Shanghai]. |
| Q95513451 | [Chronic renal disease in patients with systemic scleroderma: the prevalence and associated factors] |
| Q81477183 | [Chronic renal disease, inflammation and atherosclerosis: new concepts about an old problem] |
| Q72251984 | [Clinical analysis of the outcome of pregnancy with chronic renal disease] |
| Q70413196 | [Clinical deterioration in chronic renal disease (author's transl)] |
| Q68699574 | [Clinical neuroelectrophysiological studies on chronic renal disease] |
| Q50634993 | [Costs of interventions for patients with chronic renal disease] |
| Q100390397 | [Cross-cultural adaptation of the PAIR instrument: Pharmacotherapy Assessment in Chronic Renal Disease for application in Brazil] |
| Q79291998 | [Cystatin C as estimator of glomerular filtration rate in patients with advanced chronic renal disease] |
| Q86444615 | [Determinants of vascular wall stiffness in patients with chronic renal disease undergoing hemodialysis] |
| Q49649385 | [Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy ( |
| Q92167982 | [EVALUATION OF CARDIOVASCULAR RISKS WITH THE USE OF MORPHOGENETIC KLOTHO PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASE] |
| Q81718696 | [Early therapeutic education in chronic renal disease: a new approach.] |
| Q84693393 | [Effects of aerobic exercise during haemodialysis in patients with chronic renal disease: a literature review] |
| Q84322496 | [Epidemiology of chronic renal disease] |
| Q68652854 | [Evaluation of renal function in chronic renal disease with special reference to creatinine] |
| Q80859631 | [Fabry's disease: a form of chronic renal disease that may be diagnosed and treated] |
| Q82945386 | [Fibroblast growth factor 23 in patients with chronic renal disease: a new actor for an old part] |
| Q95820746 | [Foreword. Brazilian clinical practice guidelines for mineral and bone disorders in chronic renal disease] |
| Q80705910 | [Fresh plasma in the treatment of chronic renal disease and hypertension.] |
| Q69790464 | [Growth inhibition of erythroid colonies by autologous sera and the clinical effect of erythropoietin in chronic renal disease] |
| Q86323970 | [Growth retardation in children with chronic renal disease] |
| Q70571347 | [Growth retardation in chronic renal disease] |
| Q81217817 | [Has the prevalence of chronic renal disease increased in recent years?] |
| Q84247624 | [Hyperfiltration--early sign of chronic renal disease development in males with metabolic syndrome] |
| Q80254479 | [Hypertension in patients with chronic renal disease] |
| Q72997567 | [Immunogenicity of the 23-valent pneumococcal vaccine in children with chronic renal disease] |
| Q80244174 | [Importance of very best outpatient management of patients with chronic renal disease] |
| Q80254251 | [Influence of early stage of chronic renal disease on risk of cardiac diseases and stroke] |
| Q87384267 | [Intravenous ferric carboxymaltose for the treatment of anemia in chronic renal disease] |
| Q92974668 | [Low Body Mass Index and impact of antiretroviral therapy on nephrotoxicity, chronic renal disease among HIV-infected patients in Brazzaville, Congo] |
| Q89377082 | [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE] |
| Q82715995 | [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed] |
| Q72284430 | [Nephrocalcinosis and clinical significance in early chronic renal disease] |
| Q69451400 | [Open heart surgery in patients associated with severe chronic renal disease] |
| Q85297655 | [Oral antidiabetic drugs in chronic renal disease] |
| Q53847383 | [Oxygen affinity of haemoglobin in chronic renal disease (author's transl)] |
| Q54420083 | [Pathogenetic mechanisms of chronic renal disease progression]. |
| Q82355835 | [Perceived quality of life in children with chronic renal disease and in their parents] |
| Q80562495 | [Perspectives and usefulness of inflammatory biomarkers within the context of chronic renal disease] |
| Q75214425 | [Pleiotropic effect of statins in preventing progression of chronic renal disease] |
| Q68872571 | [Pregnancy in women with chronic renal disease] |
| Q74447364 | [Pregnancy, essential hypertension and chronic renal disease] |
| Q80897296 | [Prevention of chronic renal disease: a key issue of the nephrology mission] |
| Q85193951 | [Programmed approach to the treatment of secondary hyperparathyroidism in chronic renal disease] |
| Q79357388 | [Quality of life in chronic renal disease patients submitted to hemodialysis evaluated with SF-36 instrument] |
| Q56786559 | [Reality and future in the treatment of advanced chronic renal disease] |
| Q80867103 | [SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients] |
| Q95499491 | [Serum concentration and tubular resorption of sodium and chloride in patients with chronic renal disease] |
| Q70814167 | [Special therapy in chronic renal disease (author's transl)] |
| Q82800649 | [Specific features of cardiac insufficiency in elderly patients with chronic renal disease] |
| Q83224450 | [Strategic action of the Spanish Society of Nephrology confronting chronic renal disease ] |
| Q89915658 | [Suplemented restricted diet in old patients with chronic renal disease] |
| Q80691335 | [Treatment of anemia in patients with chronic renal disease: is it time for self-criticism?] |
| Q80562499 | [Usefulness of inflammatory biomarkers in chronic renal disease (CRD). Are they really useful in routine clinical practice for the time being?] |
| Q80989888 | [Vaccination against Hepatitis B Virus in chronic renal disease patients] |
| Q83878061 | [Variables associated with a good quality of life in patients with chronic renal disease secondary to diabetic nephropathy] |
| Q81002094 | [Vitamin D insufficiency in patients with chronic renal disease] |
| Chronic kidney disease | wikipedia | |
| 慢性腎臓病 | wikipedia |
Search more.